Tilray Inc (TO:TLRY) — Market Cap & Net Worth
Market Cap & Net Worth: Tilray Inc (TLRY)
Tilray Inc (TO:TLRY) has a market capitalization of $483.65 Million (CA$668.59 Million) as of September 19, 2026. Listed on the TO stock exchange, this Canada-based company holds position #12526 globally and #364 in its home market, demonstrating a -2.44% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Tilray Inc's stock price CA$5.59 by its total outstanding shares 119604223 (119.60 Million). Also see TLRY total assets for a full breakdown of the balance sheet.
Tilray Inc Market Cap History: 2021 to 2026
Tilray Inc's market capitalization history from 2021 to 2026. Data shows change from $771.76 Million to $483.65 Million (-20.63% CAGR). Also see Tilray Inc operating cash flow efficiency for how efficiently the company converts equity into cash flow.
Index Memberships
Tilray Inc is a constituent of 1 market index:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
S&P TSX Composite Index (Canada)
GSPTSE
|
$3.87 Trillion | 0.01% | #203 of 225 |
Weight: Tilray Inc's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Tilray Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Tilray Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Check TLRY stock price for real-time trading data and today's change.
Latest Price to Sales (P/S) Ratio
1.31x
Tilray Inc's market cap is 1.31 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2021 | $771.76 Million | $513.09 Million | -$336.01 Million | 1.50x | N/A |
| 2022 | $317.53 Million | $628.37 Million | -$434.13 Million | 0.51x | N/A |
| 2023 | $264.75 Million | $627.12 Million | -$1.44 Billion | 0.42x | N/A |
| 2024 | $164.39 Million | $788.94 Million | -$244.98 Million | 0.21x | N/A |
| 2025 | $1.07 Billion | $821.31 Million | -$2.19 Billion | 1.31x | N/A |
Competitor Companies of TLRY by Market Capitalization
Companies near Tilray Inc in the global market cap rankings as of September 19, 2026. Review TLRY tangible net assets ratio to assess the quality of the company's equity after excluding intangible assets.
Key companies related to Tilray Inc by market ranking:
- Takeda Pharmaceutical Co Ltd ADR (NYSE:TAK): Ranked #518 globally with a market cap of $52.60 Billion USD.
- GALDERMA GROUP AG (NYSE:GALDY): Ranked #613 globally with a market cap of $44.92 Billion USD.
- Takeda Pharmaceutical Company Limited (F:TKDA): Ranked #635 globally with a market cap of $43.60 Billion USD ( €37.29 Billion EUR).
- Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #670 globally with a market cap of $40.99 Billion USD ( CN¥280.10 Billion CNY).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #518 | Takeda Pharmaceutical Co Ltd ADR | NYSE:TAK | $52.60 Billion | $16.65 |
| #613 | GALDERMA GROUP AG | NYSE:GALDY | $44.92 Billion | $38.53 |
| #635 | Takeda Pharmaceutical Company Limited | F:TKDA | $43.60 Billion | €16.90 |
| #670 | Jiangsu Hengrui Medicine Co Ltd | SHG:600276 | $40.99 Billion | CN¥43.91 |
Tilray Inc Historical Marketcap From 2021 to 2026
Between 2021 and today, Tilray Inc's market cap moved from $771.76 Million to $ 483.65 Million, with a yearly change of -20.63%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | CA$483.65 Million | -54.96% |
| 2025 | CA$1.07 Billion | +553.16% |
| 2024 | CA$164.39 Million | -37.91% |
| 2023 | CA$264.75 Million | -16.62% |
| 2022 | CA$317.53 Million | -58.86% |
| 2021 | CA$771.76 Million | -- |
End of Day Market Cap According to Different Sources
On Sep 19th, 2026 the market cap of Tilray Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $483.65 Million USD |
| MoneyControl | $483.65 Million USD |
| MarketWatch | $483.65 Million USD |
| marketcap.company | $483.65 Million USD |
| Reuters | $483.65 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Tilray Inc
Tilray Brands, Inc., a lifestyle consumer products company, engages in the research, cultivation, processing, and distribution of medical cannabis products in Canada, the United States, Europe, the Middle East, Africa, and internationally. The company operates through four segments: Beverage, Cannabis, Distribution, and Wellness. It also offers medical and adult-use cannabis products; resells and… Read more